An increased expression of CD44 has been shown to effectively reverse the effects of miR-34a on bladder cancer cell proliferation and chemosensitivity of muscle invasive-bladder cancer cells (Li et al., 2022a). Here, CD44 is linked to urinary bladder cancer.